Biosign Technologies (TSXV:BIO.H) ROCE % : 0.00% (As of Sep. 2015)

View and export this data going back to 2010. Start your Free Trial

What is Biosign Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Biosign Technologies's annualized ROCE % for the quarter that ended in Sep. 2015 was 0.00%.

Biosign Technologies ROCE % Historical Data

The historical data trend for Biosign Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosign Technologies ROCE % Chart

Biosign Technologies Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

ROCE %

Get a 7-Day Free Trial

-70.78

-163.99

-128.61

-260.97

-665.32

Biosign Technologies Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
ROCE %	Get a 7-Day Free Trial															-503.84	-726.29	-306.68	-7,522.08	-

Biosign Technologies ROCE % Calculation

Biosign Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2014 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2014 )		(A: Dec. 2013 )		(A: Dec. 2014 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2014 )		(A: Dec. 2013 )		(A: Dec. 2014 )
	=	-9.687	/	( ( (4.116 - 3.173)	+	(7.556 - 5.587) )	/ 2 )
	=	-9.687	/	( (0.943	+	1.969)	/ 2 )
	=	-9.687	/	1.456
	=	-665.32 %

Biosign Technologies's ROCE % of for the quarter that ended in Sep. 2015 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2015 )		(Q: Jun. 2015 )		(Q: Sep. 2015 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2015 )		(Q: Jun. 2015 )		(Q: Sep. 2015 )
	=	25.56	/	( ( (6.281 - 6.884)	+	(4.065 - 4.221) )	/ 2 )
	=	25.56	/	( ( -0.603	+	-0.156 )	/ 2 )
	=	25.56	/	-0.3795
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2015) EBIT data.

Biosign Technologies (TSXV:BIO.H) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Biosign Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Biosign Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosign Technologies (TSXV:BIO.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Biosign Technologies Inc (TSXV:BIO.H) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

13-3715 Laird Road, Mississauga, ON, CAN, L5L 0A3

Website

http://www.biosign.com

Biosign Technologies Inc is a Canada based company engaged in the development and selling of cloud-based medical and healthcare software products. Its solutions have applications in clinic management, home care operations, health monitoring and virtual care management. The group derives its revenue from monthly recurring fees, one-time setup charges, training, professional services and the sale of hardware. The software is delivered through the cloud from the company's hosting facilities.

Biosign Technologies (TSXV:BIO.H) Headlines

No Headlines